Associated Papers
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy.
Fang W et al.
Translational Lung Cancer Research, 2020
Select a paper to view details